Difficult to Treat Depression: A free educational program exclusively for patients, families, and friends
The Mass General Hospital Department of Psychiatry invites you to attend the September symposium Difficult to Treat Depression.
The program will cover topics related to depression that are of importance to those seeking or currently receiving psychiatric treatment for themselves or loved ones. Participants will be introduced to the inventive antidepressant combination strategies that were developed as a result of the seminal STAR*D research study, as well as other medication-based strategies that have received support through psychiatric research.
The program will also cover the latest knowledge of how natural remedies may be used, alone or in combination with other therapies, for difficult to treat depression. Other topics include neuropsychiatric therapies (also known as “somatic” therapies), including electroconvulsive therapy (ECT), infrared light therapy, cranial electrical stimulation (CES), and ketamine infusion therapy.
In addition to medication-based and somatic treatments, participants will also learn how cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) have advanced the management of depression. Finally, the expert faculty will also review when and how patients and their families can use mind-body interventions including meditation, mindfulness, and yoga.
The symposium will also include presentations by members of a patient and family panel who will give a first-hand account of their journey through the recovery process and engage in a dialogue with participants, followed by a 15 minute question and answer session. We are grateful to these individuals for sharing their stories publicly and contributing their time to help others deal with the issues of depression.
We hope this program helps you and your family in the journey toward wellness.
About the Massachusetts General Hospital Department of Psychiatry
The Department of Psychiatry was established in 1934. In the course of seven decades, its scientists and clinicians have made significant contributions to the understanding and treatment of mental health disorders. Today, the department includes more than 600 affiliated psychiatrists and psychologists and has the largest clinical research program in the hospital, which includes research in neuroscience, genetics, and the assessment of new and established treatments for mental health disorders.
The Depression Clinical and Research Program (DCRP) is one of the leading centers for the study of unipolar depression worldwide. In addition to carrying out significant research activities, the DCRP is involved in delivering the highest quality clinical care through the Outpatient Psychiatry Division at MGH. The clinicians of the DCRP are known for providing comprehensive consultations and treatment to patients with depression and for employing sophisticated, state of the art pharmacotherapy strategies.
The MGH Psychiatry Academy (MGH-PA) was launched in 2005 to bring high quality continuing medical education to psychiatrists, primary care doctors, psychologists, social workers, and other health professionals around the world through live programming and the Internet. Since 2008 the MGH-PA has had more than 35,000 healthcare providers participate in live symposia and on-line activities. In 2010, the MGH-PA assumed responsibility for patient education programs that were formerly provided by the Mood and Anxiety Disorders Institute (MADI) Resource Center. The MGH-PA is now providing education for individuals, families, non-professional caregivers, and the community about mental health, translating the latest research advances into practical information to help people work with their doctors toward the most accurate diagnosis and the best possible treatment results. (www.mghcme.org and www.mghpatientfamily.org)
For information on specific needs and giving opportunities, please call the Director of Development for Psychiatry at 617-724-8799.